Long-term clinical variation of NT-proBNP in stable chronic heart failure patients

European Heart Journal

Volumn 28, Issue 2, 2007, Pages 177-182

  Schou, Morten ^a   Gustafsson, Finn ^b   Kjaer, Andreas ^b,c   Hildebrandt, Per R ^a  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chronic heart failure; Long term variation; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL;

AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; TIME FACTORS;

EID: 33847021875     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl449     Document Type: Article

References (33)

1. Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt PR. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail 2005;11:S15-S20.
2. Januzzi JL Jr, Camarco CA, Anwarruddin S, Baggish AL, Chen AA, Krauser DG, Tung R, Cameron R, Nagurney JT, Chae CU, Lloyd-Jones DM, Brown DF, Foran-Melanson S, Sluss PM, Lee-Lewandrowski E, Lewandrowski KB. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-954.
3. Gardner RS, Ozalp F, Murday AJ, Robbs SD, McDonagh TA. N-terminal probrain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735- 1743.
4. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicolls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000;355:1126-1130.
5. Hunt PJ, Yandle TG, Nicolls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995;214:1175-1183.
6. Bruins S, Fokkema MR, Romer JW, DeJongste MJ, Dijs FPL, van der Ouweland JM, van den Muskiet FA. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-2058.
7. Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-631.
8. Wu AH, Smith A. Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Eur J Heart Fail 2004;6:355-358.
9. Kroll MH. Biolocigal variation of glucose and insulin includes a deterministic chaotic component. Bio Systems 1999;50:189-201.
10. Harris EK. Some theory of Reference values. II. Comparison of some statistical models of intraindividual variation in blood constituents. Clin Chem 1976;22:1343-1350.
11. Dirksen A, Holstein-Rathlou NH, Madsen F Skovgaard LT, Ulrik CS, Heckscher T, Kock-Jensen A. Long-range correlations of serial FEV1 measurements in emphysematous patients and normal subjects. J Appl Physiol 1998;85:259-265.
12. Goldberger AL, Rigney DR. Chaos and fractals in human physiology. Sci Am 1990;262:42-49.
13. Galatius S, Gustafsson F, Nielsen PH, Atar D, Hildebrandt PR. An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area. Am Heart J 2002;144:E2.
14. Anand I, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;107:1278-1283.
15. Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA. NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 2004;6:343-350.
16. Tsutamoto T, Wada A, Maeda K, Mabuchi M, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Kinoshita M. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodelling in patients with congestive heart failure. J Am Coll Cardiol 2001;37:1228-1233.
17. Tsutamoto T, Wada A, Maeda K, Hisanage T, Fukai D, Maeda Y, Ohnishi M, Mabuchi M, Kinoshita M. Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure. Am Heart J 1997;134:910-916.
18. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stewenson LW. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002;39:1623-1629.
19. Shiga T, Hosaka F, Waukami M, Matsuda N, Tanizaki K, Kajimoto K, Shoda M, Hagiwara N, Kasanuki H. Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia. Cardiovasc Drugs Ther 2003;17:325-333.
20. Sokoll LJ, Baum H, Collinson PO, Gurr E, Haass M, Luthe H, Morton JJ, Nowatzke W, Zingler C. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 2004;42:965-972.
21. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
22. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Critical Rev Clin Lab Sci 1989;27:409-437.
23. Tsucida T, Tanabe K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol 2004;44:1-11.
24. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac BNPexpression associated with myocardial ischemia. FASEBJ 2003;17:1105-1107.
25. Lang CC, Coutie WJ, Khong TK, Choy AM. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertensions 1991;9:779-782.
26. Hoffmann U, Brueckmann M, Bertsch T, Wiessner M, Liebetrau C, Lang S, Haase KK, Borggrefe M, Huhle G. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab 2005;51:373-379.
27. Kjaer A, Hildebrandt P, Appel J. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects. Eur J Heart Fail 2004;6:29-39.
28. Smulders YM, Slaats EH, Rakic M, Smulders FT, Stehouwer CD, Silberbusch J. Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med 1998;132:39-46.
29. Gomes MB, Goncalves MF. Is there a physiological variability for albumin excretion rate? Study in patients with diabetes type 1 and non-diabetic individuals. Clin Chim Acta 2001;304:117-123.
30. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyck J, Flyvbjerg A, Hildebrandt PR. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-1762.
31. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-675.
32. Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Petersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003;89:745-751.
33. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-1718.